SCHEMBL439501

SCHEMBL439501

CC(C)N1CCC(n2nc(-c3ccccc3)[nH]c2=O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 3/20 0.45
RAMP1 O60894 2/20 0.45
OPRM1 P35372 5/20 0.41
CTSS P25774 1/20 0.41
DRD2 P14416 4/20 0.38
DRD4 P21917 4/20 0.38
DRD3 P35462 3/20 0.38
JAK2 O60674 1/20 0.38
NSD3 Q9BZ95 1/20 0.38
ALDH1A1 P00352 1/20 0.37
PARP1 P09874 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
CCR5 P51681 1/20 0.37
KCNH2 Q12809 1/20 0.37
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13313602 0.85 CALCRL (0.47) CALCRLRAMP1OPRM1CTSSDRD2
SCHEMBL12400695 0.83 CALCRL (0.47) CALCRLRAMP1CTSSDRD2DRD4
SCHEMBL13907972 0.83 CALCRL (0.47) CALCRLRAMP1CTSSDRD2DRD4
SCHEMBL404497 0.82 CALCRL (0.45) CALCRLRAMP1OPRM1CTSSDRD2
SCHEMBL13801339 0.82 CALCRL (0.46) CALCRLRAMP1CTSSDRD2DRD4
SCHEMBL12219072 0.81 HPGD (0.46) CALCRLRAMP1CTSSNSD3ALDH1A1
SCHEMBL3278017 0.81 CALCRL (0.55) CALCRLRAMP1CTSSCNR1CNR2
SCHEMBL2257145 0.80 NSD3 (0.53) CALCRLRAMP1CTSSNSD3ALDH1A1
SCHEMBL3278151 0.80 CALCRL (0.44) CALCRLRAMP1CTSSDRD2DRD4
SCHEMBL12622796 0.78 CALCRL (0.53) CALCRLRAMP1CTSSCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065190-A1 BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. 2012-03-15 US disclosed
US-7407963-B2 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2008-08-05 US disclosed
US-20070208036-A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-09-06 US disclosed
US-7230001-B1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-06-12 US disclosed
US-7230001-B1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208036-A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them ARRB1, NPY1R, ADRB3 CALCRL 4/4885RAMP1 19/4885OPRM1 18/4885
US-20120065190-A1 BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS BDKRB1, BDKRB2, CALCRL CALCRL 3/4885RAMP1 9/4885OPRM1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.